Physician profile
Robert Liu
NPI 1346771276
$13,781.49
in general payments reported to CMS, 2019-2025
23 companies · $469 in 2025
The $469 reported for 2025 was more than what 90% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $261 · 2020: $138 · 2021: $1,043 · 2022: $10K · 2023: $1,255 · 2024: $608 · 2025: $469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,278 · Travel and Lodging: $53.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,278.13 |
| Travel and Lodging | $53.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,580.01 | 2022-2024 | Octrode |
| Medtronic, INC. | $3,413.80 | 2022-2023 | Intellis Adaptivestim |
| Boston Scientific Corporation | $1,498.84 | 2021-2024 | Wavewriter Alpha Prime 16 |
| Spinal Simplicity, LLC | $1,249.57 | 2022 | |
| Nevro Corp. | $588.80 | 2022-2024 | Senza |
| Aop Health US, LLC | $441.79 | 2025 | Rapiblyk |
| Si-Bone, INC. | $426.23 | 2021-2023 | |
| Protega Pharmaceutials INC | $316.52 | 2022-2023 | Roxybond |
| Pacira Pharmaceuticals Incorporated | $228.18 | 2019-2020 | |
| Avanos Medical | $170.59 | 2024 | Generator |
| Mallinckrodt Enterprises LLC | $142.40 | 2019 | |
| Spr Therapeutics, INC | $127.85 | 2021-2023 | Sprint Pns System |
| Vertos Medical, INC. | $121.54 | 2023 | Mild Device Kit |
| Trevena, INC. | $117.67 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $96.65 | 2022-2023 | Relistor |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $93.23 | 2024 | |
| Merck Sharp & Dohme LLC | $59.72 | 2022-2025 | Bridion |
| Ibsa Pharma INC. | $26.25 | 2022-2023 | Tirosint, Licart |
| Scilex Pharmaceuticals INC. | $18.99 | 2023 | Ztlido |
| Mallinckrodt Hospital Products INC. | $17.26 | 2020 | |
| Redhill Biopharma INC. | $17.19 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $17.03 | 2024 | |
| Grifols USA, LLC | $11.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.